Low Soluble Receptor for Advanced Glycation End Products Precedes and Predicts Cardiometabolic Events in Women With Rheumatoid Arthritis

Low Soluble Receptor for Advanced Glycation End Products Precedes and Predicts Cardiometabolic Events in Women With Rheumatoid Arthritis

Background: Cardiovascular disease (CVD) causes premature mortality in rheumatoid arthritis (RA). Levels of soluble (s)RAGE change with aging, hypertension and hypercholesterolemia. We assessed whether sRAGE was associated with increased risk of CVD in RA patients.Methods: Serum sRAGE was measured i...

Full description

Bibliographic Details
Main Authors: Mitra Nadali, Lovisa Lyngfelt, Malin C. Erlandsson, Sofia Töyrä Silfverswärd, Karin M. E. Andersson, Maria I. Bokarewa, Rille Pullerits
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Medicine
Subjects:
advanced glycation end product
cardiovascular disease
soluble RAGE
rheumatoid arthritis
cardiometabolic events
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2020.594622/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2020.594622/full

Similar Items